News

The American Journal of Managed Care9h
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers
The risk of some skin cancers, including squamous cell carcinoma, basal cell carcinoma, and non-melanoma skin cancer, was ...
FDA Grants Orphan Drug Designation to NS-229 for the Treatment of Eosinophilic Granulomatosis with Polyangiitis
NS Pharma, Inc. (NS Pharma) a subsidiary of Nippon Shinyaku Co., Ltd. (Nippon Shinyaku), announced today that the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation to NS-229, ...
WGLT6h
OSF Innovator of the Year saves limbs, regenerates wounds with animal tissue
OSF HealthCare’s Innovator of the Year is performing an operation to save limbs with animal tissue at OSF St. Francis Medical ...
NS Pharma gets FDA orphan drug status for autoimmune disease
NS Pharma, a unit of Nippon Shinyaku (OTCPK:NPNKF), said on Monday that the U.S. FDA has granted orphan drug designation to ...
The American Journal of Managed Care15h
Ruxolitinib Cream and Atopic Dermatitis at AAD 2025
A panelist discusses how real-world data presented at the 2025 American Academy of Dermatology Annual Meeting (AAD 2025) ...
Terra Grounding Bed Sheet Under Review: The Grounding Co Earthing Therapy Brand
Reconnect with Earth’s Healing Energy for Better Sleep, Reduced Inflammation, and EMF Protection—The Grounding Co Launches ...
Dermatology Advisor12h
Infection Risk Varies by Systemic Therapy for Psoriatic Disease in Older Adults
Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...